HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joshua B Plummer Selected Research

Neoplasms (Cancer)

12/2020Transcriptional Activation of MYC-Induced Genes by GCN5 Promotes B-cell Lymphomagenesis.
1/2019Wwox Deletion in Mouse B Cells Leads to Genomic Instability, Neoplastic Transformation, and Monoclonal Gammopathies.
7/2015Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma.
1/2015Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells.
2/2014Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer.
2/2012Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors.
9/2011Expression of Human Endogenous Retrovirus Type K Envelope Protein is a Novel Candidate Prognostic Marker for Human Breast Cancer.
7/2008Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joshua B Plummer Research Topics

Disease

8Neoplasms (Cancer)
12/2020 - 07/2008
4Breast Neoplasms (Breast Cancer)
02/2014 - 07/2008
3Genomic Instability
05/2024 - 10/2018
2variable Immunodeficiency syndrome
12/2023 - 03/2023
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2019
1Paraproteinemias (Monoclonal Gammopathy)
01/2019
1Melanoma (Melanoma, Malignant)
07/2015
1Ovarian Diseases (Ovarian Disease)
01/2015
1Ovarian Neoplasms (Ovarian Cancer)
01/2015
1Noninfiltrating Intraductal Carcinoma (DCIS)
02/2014
1Neoplasm Metastasis (Metastasis)
02/2014
1Disease Progression
09/2011

Drug/Important Bio-Agent (IBA)

5DNA (Deoxyribonucleic Acid)IBA
12/2023 - 10/2018
5env Gene ProductsIBA
07/2015 - 07/2008
5Proteins (Proteins, Gene)FDA Link
07/2015 - 07/2008
3AntigensIBA
07/2015 - 07/2008
3AntibodiesIBA
01/2015 - 02/2012
2Messenger RNA (mRNA)IBA
02/2014 - 09/2011
1Uracil-DNA GlycosidaseIBA
05/2024
1Interleukin-5 (Interleukin 5)IBA
03/2023
1ChromatinIBA
12/2020
1Oncogene Proteins (Oncogene Protein)IBA
12/2020
1Immunoglobulin IsotypesIBA
01/2019
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2019
1Blood Proteins (Serum Proteins)IBA
01/2019
1WW Domain-Containing OxidoreductaseIBA
01/2019
1Chimeric Antigen ReceptorsIBA
07/2015
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2015
1VaccinesIBA
01/2015
1Biomarkers (Surrogate Marker)IBA
02/2014
1Immunoglobulins (Immunoglobulin)IBA
02/2012
1Monoclonal AntibodiesIBA
02/2012
1ParaffinIBA
09/2011
1DNA Transposable Elements (Element, IS)IBA
07/2008

Therapy/Procedure

2Therapeutics
12/2020 - 02/2012
1Immunotherapy
02/2012